Dennis Lefebvre; Feb 5, 2022
reference: https://www.albertahealthservices.ca/topics/Page17753.aspx
Who Is Eligible for sotrovimab or Paxlovid™? These treatments are available for patients who have a lab-confirmed COVID-19 infection if they can receive the treatment within five days of symptom onset AND they are:
1. Unvaccinated and are: •
Age 55 and older (sotrovimab) or 65 and older (Paxlovid™)
OR •
Age 18 and older with a pre-existing health condition including o o o o o
diabetes (taking medication for treatment) obesity (BMI >30) chronic kidney disease (estimated glomerular filtration rate, <60 ml per minute per 1.73 m2 of body-surface area) congestive heart failure (New York Heart Association class II, III, or IV) chronic obstructive pulmonary disease, and moderate-to-severe asthma
OR •
pregnant
OR 2. Immunocompromised, due to one of the following reasons (vaccinated or unvaccinated): • • •
have received a transplant is an oncology patients who has received a dose of any IV or oral chemotherapy or other immunosuppressive treatment since December 2020 has an inflammatory condition (e.g. rheumatoid arthritis, lupus, inflammatory bowel disease) receiving a dose of any systemic immunosuppressive treatment since December 2020
Can I Choose Whether I Receive sotrovimab or Paxlovid™? During your assessment, a physician will recommend which treatment is best for you, but you won’t be able to choose which medication you receive. If you have tested positive for COVID-19 and your symptoms began less than four days ago and you believe you meet the eligibility criteria (above), please call the dedicated Health Link line at 1844-343-0971 to find out if you qualify to receive sotrovimab or Paxlovid™ treatment.